Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Esperion Therapeutics, Inc.”

53 pharma patents match "Esperion Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 53
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 53 pharmaceutical patents matching "Esperion Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

53 results for “Esperion Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12404227

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  2. US 12398087

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  3. US 12344578

    Salt forms of bempedoic acid and methods for using the same

    Esperion Therapeutics, Inc. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  4. US 11987548

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  5. US 11926584

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  6. US 11760714

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  7. US 11744816

    Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

    Esperion Therapeutics, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  8. US 11613511

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted
  9. US 11407705

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  10. US 10941095

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  11. US 10912751

    Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

    Esperion Therapeutics, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  12. US 10118881

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  13. US 10047028

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  14. US 9624152

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  15. US 9610324

    Apolipoprotein mixtures

    Esperion Therapeutics, Inc. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  16. US 9452964

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  17. US 9006290

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted
  18. US 9000041

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  19. US 8975300

    Ketone compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  20. US 8642653

    Ketone compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted
  21. US 8623915

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted
  22. US 8497301

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted
  23. US 8309604

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  24. US 8153690

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

    Esperion Therapeutics, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted